FDA Inspection 983201 — Carter Bloodcare - Denton

Carter Bloodcare - Denton — FEI 3004853345

The FDA completed an inspection of Carter Bloodcare - Denton on August 15, 2016 in Denton, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 15, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Denton, TX (United States)